💊FDA Meeting on Reauthorization of Prescription Drug User Fee Act
The Food and Drug Administration (FDA, the Agency, or we) is hosting a public meeting to discuss proposed recommendations for the reauthorization of the Prescription Drug User Fee Act (PDUFA) for fiscal years (FYs) 2028 through 2032. PDUFA authorizes FDA to collect user fees to support the process for the review of human drug applications. The current legislative authority for PDUFA expires in September 2027. At that time, new legislation will be required for FDA to continue collecting prescription drug user fees in future fiscal years. The Federal Food, Drug, and Cosmetic Act (FD&C Act) directs that FDA begin the PDUFA reauthorization process by publishing a notice in the Federal Register requesting public input and holding a public meeting where the public may present its views on the reauthorization. FDA invites public comment as the Agency begins the process to reauthorize the program in FYs 2028 through 2032. These comments will be published and available on FDA's website.
Learn More🐟South Atlantic Fishery Management Council Public Meeting Details
The South Atlantic Fishery Management Council (Council) will hold meetings of the following: Snapper Grouper Commercial Sub- Committee; Mackerel Cobia Committee; Snapper Grouper Committee; and Joint Habitat & Ecosystem and Shrimp Committee. The meeting week will also include a formal public comment session and meetings of the Full Council.
Learn More🏛️IRS Electronic Tax Administration Advisory Committee Meeting Notice
The Electronic Tax Administration Advisory Committee will hold a public meeting.
Learn More💊FDA Announces Public Meeting on Generic Drug User Fee Reauthorization
The Food and Drug Administration (FDA, the Agency, or we) is hosting a public meeting on the reauthorization of the Generic Drug User Fee Amendments (GDUFA) for fiscal years (FYs) 2028 to 2032. At the end of September 2027, new legislation will be required for FDA to continue to collect generic drug user fees for future FYs. The Federal Food, Drug, and Cosmetic Act (FD&C Act) requires that before FDA begins negotiations with the regulated industry on GDUFA reauthorization, we publish a notice in the Federal Register requesting public input on the reauthorization; hold a public meeting at which the public may present its views on the reauthorization, including specific suggestions for changes to the goals referred to in the GDUFA Reauthorization Performance Goals and Program Enhancements Fiscal Years 2023-2027 (i.e., the GDUFA III Commitment Letter) (https://www.fda.gov/industry/ generic-drug-user-fee-amendments/gdufa-iii-reauthorization); provide a period of 30 days after the public meeting to obtain written comments from the public; and publish the comments on FDA's website. FDA invites public comment on the GDUFA program and suggestions regarding the features FDA should propose for the next GDUFA program cycle. These comments will be published and available on FDA's website.
Learn More🌊NOAA Hydrographic Services Review Panel Meeting - Engage Stakeholders
NOAA will hold a virtual Hydrographic Services Review Panel (HSRP) Federal Advisory Committee public meeting on Thursday, May 29, 2025. NOAA will accept public comments in advance and during the virtual meeting.
Learn More🌊Public Meeting Notice for Colorado River Basin Salinity Control Council
The Bureau of Reclamation (Reclamation) is publishing this notice to announce that a Federal Advisory Committee meeting of the Colorado River Basin Salinity Control Advisory Council (Council) will take place. The meeting is open to the public.
Learn More🗣️Public Meeting Notice for New Jersey Advisory Committee to USCCR
Notice is hereby given, pursuant to the provisions of the rules and regulations of the U.S. Commission on Civil Rights (Commission) and the Federal Advisory Committee Act, that the New Jersey Advisory Committee (Committee) to the U.S. Commission on Civil Rights will a public meeting via Zoom. The purpose is for the committee to discuss topic ideas.
Learn More🗣️Notice of Rhode Island Advisory Committee Public Meeting
Notice is hereby given, pursuant to the provisions of the rules and regulations of the U.S. Commission on Civil Rights (Commission) and the Federal Advisory Committee Act, that the Rhode Island Advisory Committee (Committee) to the U.S. Commission on Civil Rights will a public meeting via Zoom. The purpose is for the committee to discuss topic ideas.
Learn More🗣️Oregon Advisory Committee Meeting Notice - U.S. Commission on Civil Rights
Notice is hereby given, pursuant to the provisions of the rules and regulations of the U.S. Commission on Civil Rights (Commission) and the Federal Advisory Committee Act (FACA) that the Oregon Advisory Committee (Committee) to the U.S. Commission on Civil Rights will hold a virtual business meeting via ZoomGov on Tuesday, June 3, 2025, from 2 p.m.-3 p.m. Pacific time (PT). The purpose of the meeting is to discuss potential topics for investigation.
Learn More🗣️Public Meeting Notice for West Virginia Advisory Committee
Notice is hereby given, pursuant to the provisions of the rules and regulations of the U.S. Commission on Civil Rights (Commission) and the Federal Advisory Committee Act, that the West Virginia Advisory Committee (Committee) to the U.S. Commission on Civil Rights will hold a public business meeting via Zoom. The purpose of the inaugural meeting is to facilitate introductions among Committee members and discuss committee procedures and project process.
Learn More